Goldman Sachs Group Inc I Mab Transaction History

Goldman Sachs Group Inc

  • $706 Billion
  • Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in I Mab stock. As of the latest transaction made, Goldman Sachs Group Inc holds 10,682 shares of IMAB stock, worth $70,073. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,682
Previous 10,685 0.03%
Holding current value
$70,073
Previous $8,000 212.5%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$0.62 - $2.8 $1 - $8
-3 Reduced 0.03%
10,682 $25,000
Q3 2024

Nov 14, 2024
SELL
$1.03 - $1.72 $5,216 - $8,711
-5,065 Reduced 32.16%
10,685 $13,000
Q2 2024

Aug 13, 2024
SELL
$1.58 - $1.9 $109,321 - $131,462
-69,191 Reduced 81.46%
15,750 $26,000
Q1 2024

May 15, 2024
SELL
$1.54 - $2.37 $92,791 - $142,801
-60,254 Reduced 41.5%
84,941 $157,000
Q4 2023

Feb 13, 2024
SELL
$1.21 - $1.9 $116,372 - $182,734
-96,176 Reduced 39.85%
145,195 $275,000
Q3 2023

May 14, 2024
BUY
$1.18 - $3.06 $113,487 - $294,298
96,176 Added 66.24%
241,371 $318,000
Q3 2023

Nov 14, 2023
SELL
$1.18 - $3.06 $62,731 - $162,675
-53,162 Reduced 18.05%
241,371 $318,000
Q2 2023

May 14, 2024
SELL
$2.95 - $3.85 $190,531 - $248,659
-64,587 Reduced 17.98%
294,533 $880,000
Q2 2023

Aug 14, 2023
SELL
$2.95 - $3.85 $190,531 - $248,659
-64,587 Reduced 17.98%
294,533 $880,000
Q1 2023

May 14, 2024
SELL
$3.08 - $7.39 $533,948 - $1.28 Million
-173,360 Reduced 32.56%
359,120 $1.24 Million
Q1 2023

May 11, 2023
SELL
$3.08 - $7.39 $533,948 - $1.28 Million
-173,360 Reduced 32.56%
359,120 $1.24 Million
Q4 2022

May 14, 2024
SELL
$3.22 - $4.86 $1.95 Million - $2.94 Million
-605,858 Reduced 53.22%
532,480 $2.23 Million
Q4 2022

Feb 13, 2023
SELL
$3.22 - $4.86 $1.95 Million - $2.94 Million
-605,858 Reduced 53.22%
532,480 $2.23 Million
Q3 2022

May 14, 2024
BUY
$4.01 - $12.34 $237,163 - $729,824
59,143 Added 5.48%
1,138,338 $4.57 Million
Q3 2022

Nov 10, 2022
BUY
$4.01 - $12.34 $237,163 - $729,824
59,143 Added 5.48%
1,138,338 $4.56 Million
Q2 2022

May 14, 2024
BUY
$8.27 - $18.43 $7.72 Million - $17.2 Million
934,000 Added 643.27%
1,079,195 $12.2 Million
Q2 2022

Aug 15, 2022
BUY
$8.27 - $18.43 $2.92 Million - $6.5 Million
352,503 Added 48.51%
1,079,195 $12.2 Million
Q1 2022

May 16, 2022
BUY
$12.54 - $46.93 $4.52 Million - $16.9 Million
360,273 Added 98.32%
726,692 $11.8 Million
Q4 2021

Feb 14, 2022
BUY
$45.28 - $74.5 $7.06 Million - $11.6 Million
155,858 Added 74.02%
366,419 $17.4 Million
Q3 2021

Nov 10, 2021
BUY
$57.18 - $84.43 $12 Million - $17.8 Million
210,561 New
210,561 $15.3 Million

Others Institutions Holding IMAB

# of Institutions
40
Shares Held
14.2M
Call Options Held
10.2K
Put Options Held
0
View Full List

About I-Mab

IMAB Quotes by TradingView
  • Ticker IMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,098,800
  • Market Cap $545M
  • Description
  • I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...
More about IMAB
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email